ANNAPOLIS, Md. , July 8, 2016 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that it has received a $20 million payment from SIGA Technologies, Inc. to extend by 90 days, until October 19, 2016 , the